vs
AZZ INC（AZZ）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
AZZ INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.9倍（$385.1M vs $207.3M），AZZ INC净利率更高（4.1% vs -62.0%，领先66.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 9.4%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -3.5%）
AZZ公司是全球领先的金属防护解决方案供应商，主营热浸镀锌、表面涂层处理服务及特种电气、工业零部件，主要服务于北美及其他核心国际市场的建筑、能源、基建、制造等下游领域。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
AZZ vs RARE — 直观对比
营收规模更大
AZZ
是对方的1.9倍
$207.3M
营收增速更快
RARE
高出16.5%
9.4%
净利率更高
AZZ
高出66.2%
-62.0%
两年增速更快
RARE
近两年复合增速
-3.5%
损益表 — Q4 FY2027 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $385.1M | $207.3M |
| 净利润 | $15.9M | $-128.6M |
| 毛利率 | 22.7% | — |
| 营业利润率 | 14.8% | -54.7% |
| 净利率 | 4.1% | -62.0% |
| 营收同比 | 9.4% | 25.9% |
| 净利润同比 | 146.3% | 3.5% |
| 每股收益（稀释后） | $0.53 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AZZRARE
| Q4 26 | $385.1M | — | ||
| Q4 25 | $425.7M | $207.3M | ||
| Q3 25 | $417.3M | $159.9M | ||
| Q2 25 | $422.0M | $166.5M | ||
| Q1 25 | $351.9M | $139.3M | ||
| Q4 24 | $403.7M | $164.6M | ||
| Q3 24 | $409.0M | $139.5M | ||
| Q2 24 | $413.2M | $147.0M |
净利润AZZRARE
| Q4 26 | $15.9M | — | ||
| Q4 25 | $41.1M | $-128.6M | ||
| Q3 25 | $89.3M | $-180.4M | ||
| Q2 25 | $170.9M | $-115.0M | ||
| Q1 25 | $20.2M | $-151.1M | ||
| Q4 24 | $33.6M | $-133.2M | ||
| Q3 24 | $35.4M | $-133.5M | ||
| Q2 24 | $39.6M | $-131.6M |
毛利率AZZRARE
| Q4 26 | 22.7% | — | ||
| Q4 25 | 23.9% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 24.7% | — | ||
| Q1 25 | 22.4% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 25.3% | — | ||
| Q2 24 | 24.8% | — |
营业利润率AZZRARE
| Q4 26 | 14.8% | — | ||
| Q4 25 | 16.3% | -54.7% | ||
| Q3 25 | 16.4% | -106.9% | ||
| Q2 25 | 16.5% | -64.8% | ||
| Q1 25 | 11.5% | -102.6% | ||
| Q4 24 | 14.5% | -74.3% | ||
| Q3 24 | 16.5% | -94.6% | ||
| Q2 24 | 16.9% | -79.1% |
净利率AZZRARE
| Q4 26 | 4.1% | — | ||
| Q4 25 | 9.6% | -62.0% | ||
| Q3 25 | 21.4% | -112.8% | ||
| Q2 25 | 40.5% | -69.0% | ||
| Q1 25 | 5.7% | -108.5% | ||
| Q4 24 | 8.3% | -80.9% | ||
| Q3 24 | 8.7% | -95.7% | ||
| Q2 24 | 9.6% | -89.5% |
每股收益（稀释后）AZZRARE
| Q4 26 | $0.53 | — | ||
| Q4 25 | $1.36 | $-1.28 | ||
| Q3 25 | $2.95 | $-1.81 | ||
| Q2 25 | $5.66 | $-1.17 | ||
| Q1 25 | $0.87 | $-1.57 | ||
| Q4 24 | $1.12 | $-1.34 | ||
| Q3 24 | $1.18 | $-1.40 | ||
| Q2 24 | $-1.38 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $-80.0M |
| 总资产 | $2.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AZZRARE
| Q4 26 | — | — | ||
| Q4 25 | $623.0K | $421.0M | ||
| Q3 25 | $897.0K | $202.5M | ||
| Q2 25 | $3.0M | $176.3M | ||
| Q1 25 | $1.5M | $127.1M | ||
| Q4 24 | $1.5M | $174.0M | ||
| Q3 24 | $2.2M | $150.6M | ||
| Q2 24 | $10.5M | $480.7M |
股东权益AZZRARE
| Q4 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $-80.0M | ||
| Q3 25 | $1.3B | $9.2M | ||
| Q2 25 | $1.2B | $151.3M | ||
| Q1 25 | $1.0B | $144.2M | ||
| Q4 24 | $1.0B | $255.0M | ||
| Q3 24 | $999.8M | $346.8M | ||
| Q2 24 | $967.2M | $432.4M |
总资产AZZRARE
| Q4 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.2B | $1.3B | ||
| Q1 25 | $2.2B | $1.3B | ||
| Q4 24 | $2.2B | $1.5B | ||
| Q3 24 | $2.2B | $1.5B | ||
| Q2 24 | $2.2B | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $525.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 32.98× | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流AZZRARE
| Q4 26 | $525.4M | — | ||
| Q4 25 | $79.7M | $-99.8M | ||
| Q3 25 | $58.4M | $-91.4M | ||
| Q2 25 | $314.8M | $-108.3M | ||
| Q1 25 | — | $-166.5M | ||
| Q4 24 | $66.2M | $-79.3M | ||
| Q3 24 | $47.5M | $-67.0M | ||
| Q2 24 | $71.9M | $-77.0M |
自由现金流AZZRARE
| Q4 26 | — | — | ||
| Q4 25 | $61.2M | $-100.8M | ||
| Q3 25 | $39.1M | $-92.7M | ||
| Q2 25 | $293.9M | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | $39.7M | $-79.5M | ||
| Q3 24 | $15.4M | $-68.6M | ||
| Q2 24 | $44.5M | $-79.0M |
自由现金流率AZZRARE
| Q4 26 | — | — | ||
| Q4 25 | 14.4% | -48.6% | ||
| Q3 25 | 9.4% | -58.0% | ||
| Q2 25 | 69.6% | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | 9.8% | -48.3% | ||
| Q3 24 | 3.8% | -49.2% | ||
| Q2 24 | 10.8% | -53.7% |
资本支出强度AZZRARE
| Q4 26 | — | — | ||
| Q4 25 | 4.4% | 0.5% | ||
| Q3 25 | 4.6% | 0.8% | ||
| Q2 25 | 5.0% | 1.5% | ||
| Q1 25 | 8.5% | 1.0% | ||
| Q4 24 | 6.6% | 0.1% | ||
| Q3 24 | 7.8% | 1.2% | ||
| Q2 24 | 6.6% | 1.4% |
现金转化率AZZRARE
| Q4 26 | 32.98× | — | ||
| Q4 25 | 1.94× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 1.84× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.97× | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AZZ
| Precoat Metals | $198.6M | 52% |
| Metal Coatings | $186.5M | 48% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
